The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...
Arecor Therapeutics PLC 19 July 2024 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION...
Arecor Therapeutics PLC 19 July 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR...
Arecor Therapeutics PLC 19 July 2024 THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS...
Arecor Therapeutics PLC 28 June 2024 Arecor Therapeutics plc ("Arecor", the "Company" or the "Group") RESULT OF AGM Change of Name of...
Arecor Therapeutics PLC on Monday said it now expects to require new funding in the third quarter of this year. Sha ...
Arecor Therapeutics PLC 10 June 2024 Arecor Therapeutics plc ("Arecor" or "the Company") TRADING AND FUNDING UPDATE Cambridge, UK, 10 June...
Arecor Therapeutics PLC 31 May 2024 POSTING OF ARECOR 2023 ANNUAL REPORT AND NOTICE OF AGM Cambridge, UK, 31 May 2024. Arecor Therapeutics...
Arecor Therapeutics PLC 23 May 2024 Arecor Therapeutics plc ("Arecor", the "Company" or the "Group") Grant of Options and PDMR Dealing ...
Arecor Therapeutics PLC 21 May 2024 Arecor Therapeutics plc ("Arecor" or the "Group") ARECOR TO HOST COMPANY AND KOL WEBINAR TODAY TO...
Arecor Therapeutics PLC on Monday celebrated results of its insulin AT278. The Essex, England-based biopharmaceutica ...
Arecor Therapeutics PLC 20 May 2024 Arecor Therapeutics plc ("Arecor" or "the Company") AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.